Thomas Botton

4.9k total citations · 1 hit paper
14 papers, 2.1k citations indexed

About

Thomas Botton is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Thomas Botton has authored 14 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Thomas Botton's work include Melanoma and MAPK Pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Thomas Botton is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Thomas Botton collaborates with scholars based in France, United States and Australia. Thomas Botton's co-authors include Boris C. Bastian, A. Hunter Shain, Eric Talevich, Stéphane Rocchi, Robert Ballotti, Philippe Bahadoran, Corine Bertolotto, Iwei Yeh, María C. Garrido and Swapna S. Vemula and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Cell.

In The Last Decade

Thomas Botton

14 papers receiving 2.1k citations

Hit Papers

CNVkit: Genome-Wide Copy Number Detection and Visualizati... 2016 2026 2019 2022 2016 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Botton France 12 1.2k 821 702 354 266 14 2.1k
Young Kyung Bae South Korea 26 1.1k 0.9× 944 1.1× 691 1.0× 320 0.9× 320 1.2× 122 2.5k
Jordi Camps Spain 29 1.4k 1.2× 769 0.9× 908 1.3× 276 0.8× 357 1.3× 87 2.6k
Delphine Loussouarn France 28 976 0.8× 694 0.8× 574 0.8× 629 1.8× 117 0.4× 76 2.3k
Marc Zapatka Germany 30 1.5k 1.3× 921 1.1× 674 1.0× 186 0.5× 264 1.0× 80 2.6k
Robert McEwen United Kingdom 20 1.1k 0.9× 613 0.7× 651 0.9× 495 1.4× 171 0.6× 37 2.2k
Claudia Scholl Germany 32 2.7k 2.2× 688 0.8× 674 1.0× 353 1.0× 239 0.9× 72 4.2k
Byungwoo Ryu United States 20 1.7k 1.4× 1.3k 1.6× 568 0.8× 370 1.0× 216 0.8× 39 2.9k
Yusuke Nakamura Japan 27 1.5k 1.2× 773 0.9× 627 0.9× 352 1.0× 355 1.3× 84 2.7k
Paola Ghiorzo Italy 26 1.1k 0.9× 1.1k 1.3× 528 0.8× 129 0.4× 237 0.9× 79 1.9k
Ying C. Henderson United States 25 1.3k 1.0× 1.0k 1.2× 509 0.7× 236 0.7× 337 1.3× 39 2.4k

Countries citing papers authored by Thomas Botton

Since Specialization
Citations

This map shows the geographic impact of Thomas Botton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Botton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Botton more than expected).

Fields of papers citing papers by Thomas Botton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Botton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Botton. The network helps show where Thomas Botton may publish in the future.

Co-authorship network of co-authors of Thomas Botton

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Botton. A scholar is included among the top collaborators of Thomas Botton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Botton. Thomas Botton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Botton, Thomas, et al.. (2023). Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5‐Triazin‐2‐one Ring Opening. ChemMedChem. 19(3). e202300493–e202300493. 1 indexed citations
2.
Jaune, Emilie, Cyril Ronco, Patricia Abbe, et al.. (2021). Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies. Cell Death and Disease. 12(1). 19 indexed citations
3.
Botton, Thomas, Eric Talevich, Vivek Kumar Mishra, et al.. (2019). Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Reports. 29(3). 573–588.e7. 72 indexed citations
4.
Montesion, Meagan, Thomas Botton, Eric A. Collisson, et al.. (2018). Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion. The Oncologist. 23(9). 998–1003. 3 indexed citations
5.
Zeng, Hanlin, Aparna Jorapur, A. Hunter Shain, et al.. (2018). Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation. Cancer Cell. 34(1). 56–68.e9. 86 indexed citations
6.
Talevich, Eric, A. Hunter Shain, Thomas Botton, & Boris C. Bastian. (2016). CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. PLoS Computational Biology. 12(4). e1004873–e1004873. 1090 indexed citations breakdown →
7.
Yeh, Iwei, Meng Kian Tee, Thomas Botton, et al.. (2016). NTRK3 kinase fusions in Spitz tumours. The Journal of Pathology. 240(3). 282–290. 119 indexed citations
8.
Yeh, Iwei, Thomas Botton, Eric Talevich, et al.. (2015). Activating MET kinase rearrangements in melanoma and Spitz tumours. Nature Communications. 6(1). 7174–7174. 120 indexed citations
9.
Botton, Thomas, Iwei Yeh, Tyrrell A. Nelson, et al.. (2013). Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell & Melanoma Research. 26(6). 845–851. 96 indexed citations
10.
Chéli, Yann, Thomas Botton, Stéphane Rocchi, et al.. (2011). Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene. 30(20). 2307–2318. 172 indexed citations
11.
Tomić, Tijana, Thomas Botton, Michaël Cerezo, et al.. (2011). Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death and Disease. 2(9). e199–e199. 250 indexed citations
12.
Vauchelles, Romain, Danièle Stalder, Thomas Botton, Robert A. Arkowitz, & Martine Bassilana. (2010). Rac1 Dynamics in the Human Opportunistic Fungal Pathogen Candida albicans. PLoS ONE. 5(10). e15400–e15400. 12 indexed citations
13.
Botton, Thomas, Alexandre Puissant, Yann Chéli, et al.. (2010). Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth. Cell Death and Differentiation. 18(1). 109–121. 30 indexed citations
14.
Botton, Thomas, Alexandre Puissant, Philippe Bahadoran, et al.. (2009). In Vitro and In Vivo Anti-Melanoma Effects of Ciglitazone. Journal of Investigative Dermatology. 129(5). 1208–1218. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026